title: Alternative targeted therapy for early Her2 positive breast cancer.
authors.affiliation: 1 Department of Medical Oncology, Bankstown-Lidcombe Hospital, Sydney NSW, Australia ; 2 Deakin University Research Fellow, Andrew Love Cancer Centre, Geelong VIC, Australia.
authors.forename: Sandra L
authors.initials: SL
authors.lastname: Harvey
authors.affiliation: 1 Department of Medical Oncology, Bankstown-Lidcombe Hospital, Sydney NSW, Australia ; 2 Deakin University Research Fellow, Andrew Love Cancer Centre, Geelong VIC, Australia.
authors.forename: Mustafa
authors.initials: M
authors.lastname: Khasraw
references.citation: Lancet Oncol. 2013 Jan;14(1):88-96
references.pmid: 23234763
references.citation: Lancet Oncol. 2012 Feb;13(2):135-44
references.pmid: 22257523
references.citation: Breast Cancer Res Treat. 2012 Aug;134(3):1095-102
references.pmid: 22476857
references.citation: Lancet. 2012 Feb 18;379(9816):633-40
references.pmid: 22257673
references.citation: N Engl J Med. 2012 Nov 8;367(19):1783-91
references.pmid: 23020162
references.citation: N Engl J Med. 2005 Oct 20;353(16):1659-72
references.pmid: 16236737
references.citation: J Clin Oncol. 1992 Jul;10(7):1049-56
references.pmid: 1351538
references.citation: Lancet Oncol. 2012 Sep;13(9):869-78
references.pmid: 22884505
references.citation: J Clin Pathol. 2011 Dec;64(12):1112-6
references.pmid: 22011446
references.citation: Lancet Oncol. 2011 Mar;12(3):236-44
references.pmid: 21354370
references.citation: Lancet Oncol. 2012 Jan;13(1):25-32
references.pmid: 22153890
references.citation: N Engl J Med. 2006 Feb 23;354(8):809-20
references.pmid: 16495393
references.citation: N Engl J Med. 2005 Oct 20;353(16):1673-84
references.pmid: 16236738
references.citation: N Engl J Med. 2011 Oct 6;365(14):1273-83
references.pmid: 21991949